<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease is a <z:hpo ids='HP_0011010'>chronic</z:hpo> relapsing systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> of unknown origin in which orogenital ulceration, <z:mp ids='MP_0001212'>skin lesions</z:mp> and <z:hpo ids='HP_0000554'>uveitis</z:hpo> are prominent features </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with BD have been recognized to be at greater risk for <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> such as <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000554'>Uveitis</z:hpo> in BD is usually accompanied by <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C0948441" disease_type="Disease or Syndrome" abbrv="VOD">vaso-occlusive disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: To investigate the possible role of <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> as a prethrombotic disorder in the development of <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: The study population consisted of 29 patients with BD (13 males and 16 females with a mean age of 32.3 years, range 21-52) and 24 healthy controls </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients fulfilled the criteria of the International Study Group for BD </plain></SENT>
<SENT sid="6" pm="."><plain>The patients were categorized as having active (n = 8) or inactive disease (n = 11) or only <z:hpo ids='HP_0000554'>uveitis</z:hpo> (n = 10) </plain></SENT>
<SENT sid="7" pm="."><plain>Plasma fasting <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and C-reactive protein levels were studied in <z:hpo ids='HP_0000001'>all</z:hpo> patients and controls </plain></SENT>
<SENT sid="8" pm="."><plain>The fasting <z:chebi fb="0" ids="17230">homocysteine</z:chebi> level was significantly higher in patients with only <z:hpo ids='HP_0000554'>uveitis</z:hpo> than in inactive patients and controls (P = 0.029 and P = 0.26 respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>It was also higher in patients with active disease compared to healthy controls (P = 0.,001) </plain></SENT>
<SENT sid="10" pm="."><plain>However, no significant difference was found between <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels of patients with active or inactive disease (P = 0.69) </plain></SENT>
<SENT sid="11" pm="."><plain>CRP, as a marker of disease activity, was higher in active BD and in patients with only <z:hpo ids='HP_0000554'>uveitis</z:hpo> than in controls (P = 0.01 and P = 0.001 respectively) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="17230">Homocysteine</z:chebi> may play a role in ocular involvement of BD </plain></SENT>
<SENT sid="13" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> can induce <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, thereby leading to <z:mp ids='MP_0005048'>thrombosis</z:mp> in the <z:chebi fb="46" ids="15035">retinal</z:chebi> vascular bed in a way similar to that recently proposed for the pathogenesis of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
</text></document>